Ibrutinib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: Instructions Ibrutinib | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Ibrutinib included in the composition |
Prices in pharmacies |
Imbruvica | 4850€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 64% Akalabrutinib
- 57% Lophenalac
- 56% Cytarabine
- 48% Imatinib
- 48% Dasatinib
- 47% Rufocromomycin
- 46% Paphencyl
- 45% Chlorethylaminouracil
- 45% Nilotinib
- 42% Bosutinib
- 41% Fludarabine
- 40% Busulfan
- 39% Asparaginase
- 37% Lipegfilgrastim
- 36% Dipin
- 32% Lorlatinib
- 32% Daunorubicin
- 31% Mercaptopurine
- 31% Venetoclax
- 30% Vindesine
- 30% Dibrospidium chloride
- 29% Febuxostat
- 28% Hydroxycarbamide
- 27% Procarbazine
- 27% Nitrosomethylurea
- 26% Prodimin
- 25% Nintedanib
- 24% Immunoglobulin human normal
- 24% Chlorambucil
- 24% Pazopanib
- 23% Nelarabine
- 23% Tioguanine
- 22% Sorafenib
- 22% Trametinib
- 22% Topotecan
- 22% Nimustine
- 22% Ixazomib
- 22% Cabozantinib
- 21% Regorafenib
- 21% Abemaciclib
- 21% Teniposide
- 21% Carubicin
- 21% Pumitepa
- 20% Bleomycin
- 20% Palbociclib
- 20% Idarubicin
- 20% Fotretamine
- 19% Epoetin alfa
- 18% Lenograstim
- 18% Cyclophosphamide
Learn more about the selection of analogues
- The drug has «Ibrutinib» 51 analog by action, the most similar - Akalabrutinib .
- Medical online service has selected the best substitutes for Ibrutinib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Ibrutinib analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.